Atlas Antibodies to Showcase Innovation at the Society for Neuroscience Annual Meeting 2024 in Chicago
We at Atlas Antibodies are excited to announce participation in the Society for Neuroscience (SFN) 2024 Annual Meeting (Chicago, October 5-9), where our company will be exhibiting and presenting the newest developments in neuroscience research tools.
We invite researchers, collaborators, and all attendees of SFN 2024 to visit Atlas Antibodies at Booth 1275, where our team of experts will be available to discuss our products, answer questions, and explore potential collaborations.
Introducing MolBoolean: Beyond Proximity Ligation
One of the key highlights of Atlas Antibodies' exhibit at SFN 2024 will be the presentation of MolBoolean, a pioneering product in proteomics. MolBoolean™ is a novel in situ proximity technology developed by Atlas Antibodies that enables the simultaneous detection of free and interacting fractions for two protein targets.
Poster presentation based on MolBoolean technology
Our scientists will also present poster #8217, "Quantifying dopamine D2 and adenosine A2A receptor interactions in rat brain using MolBoolean™ technology", on Sunday, October the 6th, 2-3 PM (authors: Mikael Malmqvist, André Charbonneau, Carolyn Marks, and Eugenia Kuteeva).
The research team from Atlas Antibodies has successfully used a newly developed MolBoolean™ technology for detecting individual and interacting ADORA2 and DRD2 receptor proteins in the rat brain. Moreover, a combination of MolBoolean™ with IHC-IF enabled the quantification of protein interactions in distinct cell subpopulations, including neurons and astrocytes. Our data demonstrated that MolBoolean™ can be used as a powerful tool for dissecting protein-protein interactions.
Mapping the Brain Proteome: Neuroscience Campaign
In addition to unveiling MolBoolean, Atlas Antibodies will showcase its soon-ongoing Neuroscience campaign, which focuses on providing primary antibodies for mapping the brain proteome. To advance the understanding of protein expression and localization in both healthy and diseased brains, Atlas Antibodies offers a comprehensive range of validated primary antibodies targeting key neural markers.
Explore more about SFN Congress
Our connection to the Human Protein Atlas (HPA)
Atlas Antibodies will also emphasize its connection to the renowned Human Protein Atlas (HPA) project. This global initiative has been instrumental in mapping human proteins across tissues and organs, including the brain.
As a trusted supplier of reagents based on HPA-generated antibodies, Atlas Antibodies plays a crucial role in bridging cutting-edge research with practical applications in neuroscience. These antibodies, rooted in HPA data, offer researchers validated tools for exploring protein function, expression, and distribution with precision and reliability.
Stay tuned for more updates, and we look forward to seeing you in Chicago!